Lactulose Novalie (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged. Gut bacteria break it down into acidic metabolites, lowering colonic pH. This creates an osmotic gradient that draws water into the bowel, softening stool, while the acidic environment converts ammonia to ammonium, which is poorly absorbed, thereby lowering systemic ammonia levels.

The appropriate dose of Lactulose Novalie is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Dosage may be adjusted during treatment to achieve the desired clinical effect while minimizing adverse reactions.

Safety data for Lactulose Novalie in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing to pregnant or nursing women. The decision should be individualized and made in consultation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the team provides pricing, availability, shipping details, and assists with any necessary import documentation.

Lactulose is an osmotic laxative that works by increasing water content in the colon, whereas stimulant laxatives such as bisacodyl act by stimulating intestinal motility. Compared with bulk‑forming agents, Lactulose provides a rapid softening effect and also offers the unique benefit of lowering ammonia levels, making it useful in hepatic encephalopathy.

Lactulose Novalie should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lactulose Novalie is taken orally, usually as a liquid or tablet, as directed by the prescriber. It can be mixed with water or other suitable fluids if a liquid formulation is used. The dose is typically spaced throughout the day to maintain consistent therapeutic effect.

Serious risks include severe electrolyte imbalance, dehydration, and rare allergic reactions such as rash, swelling, or difficulty breathing. Patients should be monitored for signs of these conditions, especially during high‑dose or prolonged therapy, and seek medical attention if they occur.

Lactulose Novalie is contraindicated in individuals with known hypersensitivity to lactulose or any of its excipients. Caution is advised for patients with severe intestinal obstruction, acute abdominal conditions, or those requiring strict fluid restriction, as the osmotic effect may exacerbate these issues.